Skip to main content

Table 3 Adverse events

From: Phase I prospective trial of TAS-102 (trifluridine and tipiracil) and radioembolization with 90Y resin microspheres for chemo-refractory colorectal liver metastases

Toxicity / Grade

Grade 1,

N (%)

Grade 2,

N (%)

Grade 3,

N (%)

Grade 4,

N (%)

Clinical

 Abdominal pain

11 (52)

5 (24)

 Anorexia

6 (29)

2 (10)

 Back pain

5 (24)

 Constipation

5 (24)

 Diarrhea

9 (43)

2 (10)

1 (5)

 Dysgeusia

4 (19)

1 (5)

 Emesis

7 (33)

1 (5)

 Fatigue

7 (33)

4 (19)

 Fever

4 (19)

 Headache

3 (14)

 Insomnia

4 (19)

 Nausea

10 (48)

3 (14)

 Night sweats

3 (14)

Laboratory

 ALT elevation

8 (38)

1 (5)

 AST elevation

10 (48)

4 (19)

 Bilirubin elevation

3 (14)

3 (14)

2 (10)

 Hypoalbuminemia

3 (14)

2 (10)

2 (10)

 Anemia

3 (14)

3 (14)

5 (24)

 Leukopenia

2 (10)

4 (19)

4 (19)

1 (5)

 Neutropenia

2 (10)

3 (14)

7 (33)

3 (14)

 Neutropenic fever

1 (5)

 Thrombocytopenia

8 (38)

4 (19)

1 (5)